ST. VINCENT HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.4M
- Transactions
- 119
- Companies
- 32
- Average per transaction
- $11,824
Who reported the payments
| Eli Lilly | $583,420 |
| Smith+Nephew | $195,915 |
| Astrazeneca UK Limited | $125,224 |
| Pfizer | $105,091 |
| AstraZeneca | $73,097 |
| Coherus Oncology, Inc. | $72,525 |
| Janssen Research & Development, LLC | $58,289 |
| E.r. Squibb & Sons, L.L.C. | $56,012 |
| Stryker | $31,059 |
| Merck | $14,530 |
| Array Biopharma Inc | $10,000 |
| Johnson & Johnson | $10,000 |
| AbbVie | $7,150 |
| National Marrow Donor Program | $7,000 |
| Bristol Myers Squibb | $5,750 |
| Progenics Pharmaceuticals, Inc. | $5,175 |
| Seagen Inc. | $5,000 |
| Bayer | $5,000 |
| Takeda Pharmaceuticals U.S.A., Inc. | $5,000 |
| Jazz Pharmaceuticals Inc. | $5,000 |
| Neurocrine Biosciences, Inc. | $4,500 |
| Baxter Healthcare | $4,459 |
| Qiagen, LLC | $4,340 |
| GE HealthCare | $3,738 |
| Siemens Medical Solutions USA, Inc. | $3,690 |
| Insulet Corporation | $2,250 |
| Intuitive Surgical | $2,000 |
| Zimmer Biomet | $1,318 |
| Cochlear Americas | $388 |
| BD | $101 |
| B. Braun Interventional Systems Inc. | $58 |
| Bio-rad Laboratories, Inc. | $30 |